Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Adenocarcinoma Of Esophagus 2Urothelial Bladder Carcinoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Tumor 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Liposarcoma 1Glioblastoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Non-Small Cell Lung Cancer 1

Interventions

pembrolizumab 3zimberelimab 1tilsotolimod 1sintilimab 1sacituzumab govitecan 1niraparib 1encorafenib 1cobimetinib 1cedazuridine 1binimetinib 1atezolizumab 1Radiosurgery 1Proton Therapy 1Nivolumab 1Ipilimumab 1Everolimus 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Solid Tumor × zimberelimab × Clear all
NCT05840224 2026-01-28

Study of GS-4528 in Adults With Solid Tumors

Gilead Sciences

Phase 1 Active not recruiting
182 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡